Athanasiou Thanos, Ashrafian Hutan, Rowland Simon P, Casula Roberto
Department of Surgery & Cancer, Imperial College London, London W2 1NY, UK.
Future Cardiol. 2011 Jul;7(4):511-22. doi: 10.2217/fca.11.40.
Robotic cardiac surgery utilizes the most advanced surgical technology to offer patients a minimally invasive alternative to open surgery in the treatment of a broad range of cardiac pathologies. Although robotics may offer substantial benefits to physicians, patients and healthcare institutions, there are important barriers to its adoption that includes inadequate funding, competition from alternate therapies and challenges in training. There is a growing body of evidence to demonstrate the efficacy of robotic cardiac surgery. Technological innovations are improving patient safety and expanding the indications for robotic cardiac surgery beyond the treatment of mitral valve and coronary artery disease. Robotic cardiac surgery is rapidly becoming a feasible, safe and effective option for the definitive treatment of cardiac disease in the context of 21st century challenges to healthcare provision such as diabetes, obesity and an aging population.
机器人心脏手术利用最先进的手术技术,为患者提供一种微创替代方案,用于治疗多种心脏疾病,以取代开胸手术。尽管机器人技术可能会给医生、患者和医疗机构带来诸多益处,但在其应用过程中存在一些重要障碍,包括资金不足、来自替代疗法的竞争以及培训方面的挑战。越来越多的证据表明机器人心脏手术的有效性。技术创新正在提高患者安全性,并将机器人心脏手术的适应症扩大到二尖瓣和冠状动脉疾病之外。在21世纪医疗保健面临的挑战(如糖尿病、肥胖症和人口老龄化)背景下,机器人心脏手术正迅速成为治疗心脏病的一种可行、安全且有效的选择。